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Value of Monitoring Serum
Immunoglobulins Questioned
Our journal club's review of the recent
article by Szczeklik al. (EHP 102:302-
304) found fault on many levels, especially
with the concluding recommendation. It
would be neither practical nor useful for
workers exposed chronically to PAHs to
have serum immunoglobulin levels moni-
tored regularly. The use of cross-sectional
data regarding serum immunoglobulin lev-
els for detecting immune competence is
not clinically sound. Except in patients
with congenital deficiencies, there is no
correlation between these levels and resis-
tance to infection. There is no basis to
compare mean values within the statistical-
ly normal range in the expectation that
changes reflect immunosuppression. If
humoral immune competence is to be eval-
uated, a useful test involves assessment of
the dynamic response to a particular anti-
gen challenge. This biological function has
been shown to diminish following in vitro
exposure to benzo[a]pyrene, but there is
little basis for linking this effect to cancer
consequences.
Polycyclic aromatic hydrocarbons are
not clinically linked to the development of
opportunistic infections, the most signifi-
cant sign of immune suppression. Even if
this type of immune deficit had been
shown in these workers, there is no basis to
make the assertion that humoral immuno-
competence has any role in carcinogenesis.
Cancer immune surveillance is most signif-
icantly accomplished by tumor-infiltrating
and T-cell lymphocytes, especially CD8
cells and the helper CD4 cells. Patients
with early and even late-stage cancer usual-
ly have normal or elevated levels of total
serum immunoglobulin, the opposite effect
ofSzczeklik's workers.
Lastly, the paper's own data refute the
routine monitoring of exposure with this
biological tool. No correlation with dura-
tion or magnitude of exposure was identi-
fied among these heavily exposed workers.
The published graph ofthe groups intense-
ly overlapping IgG results provides a
strong argument against any use ofthis test
in worker monitoring.
Critical scrutiny is necessary before
introducing routine clinical tests, especially
in workplace health and safety. In the set-
ting described in the Szczeklik paper,
expenditures on exposure evaluation and
reduction by traditional industrial hygiene
methods would be more useful than any
biological monitoring. In the clinical arena,
education and counseling to decrease the
workers astonishing 75% prevalence of
active smokingwould be essential.
GaryN. Greenberg
Lane Tippens
Occupational Medicine
Duke University Medical Center
Response
Greenberg and Tippens's assertion that
measurement ofserum immunoglobulins is
oflittle value in testing humoral immunity
flies in the face ofwell-established clinical
knowledge. So does the statement that
"Except in patients with congenital defi-
ciencies, there is no correlation between
these [serum immunoglobulin] levels and
resistance to infection." Examples refuting
the latter statement include certain forms of
late-onset hypogammaglobulinemia, also
called common variable immunodeficiency,
malnutrition, Epstein-Barr virus infection,
and depression of serum immunoglobulins
caused by high doses ofcyclophosphamide
or bycorticosteroid use in nonatopic (infec-
tious) asthma.
Greenberg and Tippens declare: "there is
no basis to compare mean values" between
the two groups. Why not? The groups were
well matched, differing only with regard to
chronic PAH exposure. Mathematical analy-
sis revealed that mean serum IgG and IgA
differed with high statistical probability
(p<O.Ol) between the groups. Moreover, in
the group of coke-oven workers, 21.5% of
the subjects had IgG levels <1000 mg/dl,
and 5% had <700 mg/dl. Such a distinct
depression ofserum immunoglobulin would
be ofconcern to anyclinician.
We have demonstrated for the first
time in humans that chronic exposure to
high PAH concentrations leads to humoral
immunosuppression. Based on this find-
ing, we have suggested that workers
exposed chronically to high PAH concen-
trations should have serum immunoglobu-
lins monitored regularly. A similar conclu-
sion was recently reached by Saboori and
Newcombe (1), based on their comprehen-
sive review of the existing evidence of
immunotoxic effects of PAH in animal
studies. The fact that we have not observed
a correlation between the length of expo-
sure and serum immunoglobulin levels
does not detract from the value of im-
munoglobulin monitoring. Other factors
that we did not evaluate, such as genetic
susceptibility or personal exposure, most
likely had a significant effect on the
immune response.
We agree with Greenberg and Tippens
that there is no proof that immunosup-
pression, as demonstrated by us, is causally
related to the high rate of malignancy
among coke-oven workers. We did not
make such an assertion, the proofofwhich
would require prospective studies. We
share the view of Greenberg and Tippens
that cigarette smoking does not promote
health and should be counteracted.
AndrewSzczeklik
Department ofMedicine
Jagiellonian University
Cracow, Poland
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PAH Cleanup in Illinois
The article entitled "Establishing Generic
Remediation Goals for the Polycyclic
Aromatic Hydrocarbons: Critical Issues"
by Peter K. LaGoy and Thamsen C.
Quirk in the April 1994 edition of
Environmental Health Perspectives (102:
348-352) reported soil remediation goals
proposed by various state regulatory agen-
cies, including Illinois, for carcinogenic
PAHs. The objectives reported in this
article are incorrect. The cleanup objec-
tives reported by the authors do not
match those in Table 2 ofthe 1991 refer-
ence which they cite. An updated version
of the reference cited by the authors was
published February 1993. A copy of
those soil cleanup objectives and accept-
able detection limits is included as Table
3 ofthe 1993 document. However, there
is currently a regulatory proceeding
before the Illinois Pollution Control
Board that may or may not change the
1993 objectives.
We are concerned that the article por-
trays the Illinois approach as simplistic by
setting one cleanup objective for the car-
cinogenic PAHs, when, in fact, there is a
great deal of support behind these objec-
tives. Please print this letter in order to
clear up any misunderstanding among the
regulated community.
James P. O'Brien
Office ofChemical Safety
Illinois Environmental ProtectionAgency
730 Environmental Health Perspectives